Combining classical gene expression approaches with innovative algorithm classifier analyses, we were able to depict an “identity card” of LR after PH and to identify Trα, Fxrβ and Pparδ as candidate biomarkers and putative targets for the pharmacological modulation of LR, with a potential application in liver disease and HCC. This evidence concerns the gene NR1H5P and hepatocellular carcinoma.